Role of Magnetic Resonance Spectroscopy Using Choline Peak as A Malignancy Marker In Diagnosis Of Suspicious Breast Lesions (BIRADS III and IV)

Mohamed Abo Elhoda Darwish1; Dalia Zaki Zidan1; Nivine Abdel Moneim Chalabi2; Mai Mokhtar Kamal Mahmoud Barakat3; Mokhtar, Mai;

Abstract


Role of Magnetic Resonance Spectroscopy Using CholinePeak as A Malignancy Marker In Background: BIRADS III and IV lesions are a clinical dilemma as they need either follow up or biopsy. Since 80% of lesions determined in the breast are benign upon biopsy, we need new methods for evaluation of this lesions to avoid unnecessarybreast interventions .MR spectroscopy is a promising new technique which can be used to improve the diagnosis of breast lesions classified according to BIRADS category .The diagnostic value of H-MRS is typically based on the elevation of choline compounds which are the markers of malignancy and aid in the differentiationbetween benign and malignant breast lesions .Aim of the Work: To assess the diagnostic value of MR spectroscopy using cholinepeak as a malignancy marker in diagnosis of suspicious breast lesions categorized bymammography or sonomamography as (BIRADS III, IV) and correlation withavailable histopathological findings, clinical data or follow up.Material and Methods: In this study 35 female patients classified as BIRADS III & IV by sono-mammography (Sono-MX) or sonography were examined by conventional dynamic MRI and proton MR spectroscopy using a magnet (1.5 Tesla).Single voxel technique after adequate shimming was used.Results: 18 out of 35 patients had BIRADS III Lesions and 17 were BIRADS IV .25lesions were benign (71.4%) (7 of them were BIRADS IV lesions and 18 wereBIRADS III lesions), and 10 were malignant (28.6%) (all of them BIRADS IVlesions). A choline peak was present in 13 lesions (37.1%) of 35 and in 3 of 18benign lesions. Calculated MR spectroscopy sensitivity was 100 % and specificity 88%. Positive predictive value was 76.9 %, false positive rate was 12.0%, Correctclassification was 91.4%. Conclusion: Breast single MRS can increase the specificity of the conventionaldynamic MRI in evaluating breast lesions classified as (BIRADS III and BIRADS IV)and hence reduced the number of unnecessary biopsies.Key words: MR spectroscopy, Choline, Suspicious, BIRADS III and IV.


Other data

Title Role of Magnetic Resonance Spectroscopy Using Choline Peak as A Malignancy Marker In Diagnosis Of Suspicious Breast Lesions (BIRADS III and IV)
Other Titles Role of magnetic resonance spectroscopy using choline peak as a malignancy marker in diagnosis of breast lesions classified BIRADS III and IV
Authors Mohamed Abo Elhoda Darwish1; Dalia Zaki Zidan1; Nivine Abdel Moneim Chalabi2; Mai Mokhtar Kamal Mahmoud Barakat3 ; Mokhtar, Mai 
Keywords MR spectroscopy;Choline;Suspicious;BIRADS III and IV
Issue Date Aug-2016
Journal Ain Shams Medical Journal 
Conference ECR 2017 = European Congress of Radiology 2016Scientific Paper (Control number: 1546) entitled "Role of magnetic resonance spectroscopy using choline peak as a malignancy marker in diagnosis of breast lesions classified BIRADS III and IV" has been accepted for ECR 2017, 
Description 
Scientific Paper (Control number: 1546) entitled "Role of magnetic resonance spectroscopy using choline peak as a malignancy marker in diagnosis of breast lesions classified BIRADS III and IV" has been accepted for ECR 2017,

Recommend this item

Similar Items from Core Recommender Database

Google ScholarTM

Check

views 16 in Shams Scholar


Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.